ENDO TOOLS THERAPEUTICS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
ENDO TOOLS THERAPEUTICS
NACE 86.995, Nutrition and dietetics services
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€9.9m
2024 · -€5.7m-€4.2m
Equity
-€15.1m
2024 · -€5.1m-€9.9m
Cash
€216,889
2024 · €243,955-€27,066
Balance sheet total
€5.1m
2024 · €4.8m+€297,006
Largest movements
Assets
- Intangible fixed assets +€293,374
up €293,374 (+10.7%), from €2.7m to €3.0m
- Stocks and contracts +€59,148
up €59,148 (+6.5%), from €907,687 to €966,834
Equity and liabilities
- Current portion of long-term debt +€14.5m
up €14.5m (+1,125%), from €1.3m to €15.8m
- Profit (loss) carried forward -€9.9m
down €9.9m (-70.1%), from -€14.2m to -€24.1m
- Debts after one year -€5.7m
down €5.7m (-75.5%), from €7.5m to €1.8m
- Short-term financial debts +€1.1m
up €1.1m (+6,506%), from €16,425 to €1.1m
of which Other loans: +€1.1m
- Trade debts +€330,752
up €330,752 (+36.4%), from €909,165 to €1.2m
Income statement
- Financial charges +€4.3m
up €4.3m (+1,326%), from €324,773 to €4.6m
- Gross operating margin +€241,574
up €241,574 (+9.7%), from -€2.5m to -€2.2m
- Depreciation +€168,162
up €168,162 (+18.6%), from €902,263 to €1.1m
- Staff costs -€37,230
down €37,230 (-1.8%), from €2.1m to €2.1m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€5.7m
Gross operating margin
+€241,574
Staff costs
+€37,230
Depreciation
-€168,162
Write-downs
+€12,600
Other operating charges
-€233
Financial income
-€9,632
Financial charges
-€4.3m
Taxes
-€6,814
Result 2025
-€9.9m
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€8.6m
Investment
-€1.3m
Financing
+€9.9m
Cash 2024
€243,955
From operations (derived)
-€8.6m
Net result for the year
-€9.9m
Depreciation
+€1.1m
Smaller working-capital items
-€5,403
Stocks and contracts
-€59,148
Trade debts
+€330,752
Investment (derived)
-€1.3m
Investment in fixed assets (net)
-€1.3m
Financing
+€9.9m
Debts after one year
-€5.7m
Current portion of long-term debt
+€14.5m
Short-term financial debts
+€1.1m
Cash 2025
€216,889
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,809,464 | €5,106,470 | +€297,006 | +6.2% |
| Fixed assets | 21/28 | €3,185,262 | €3,457,122 | +€271,860 | +8.5% |
| Intangible fixed assets | 21 | €2,737,115 | €3,030,490 | +€293,374 | +10.7% |
| Tangible fixed assets | 22/27 | €64,349 | €63,353 | -€995 | -1.5% |
| Plant, machinery and equipment | 23 | €58,749 | €61,051 | +€2,302 | +3.9% |
| Furniture and vehicles | 24 | €5,600 | €2,302 | -€3,297 | -58.9% |
| Financial fixed assets | 28 | €383,798 | €363,279 | -€20,519 | -5.3% |
| Current assets | 29/58 | €1,624,202 | €1,649,348 | +€25,146 | +1.5% |
| Amounts receivable after more than one year | 29 | €165,370 | €182,931 | +€17,560 | +10.6% |
| Other amounts receivable | 291 | €165,370 | €182,931 | +€17,560 | +10.6% |
| Stocks and contracts in progress | 3 | €907,687 | €966,834 | +€59,148 | +6.5% |
| Stocks | 30/36 | €907,687 | €966,834 | +€59,148 | +6.5% |
| Amounts receivable within one year | 40/41 | €257,567 | €259,201 | +€1,634 | +0.6% |
| Trade receivables | 40 | €142,741 | €166,294 | +€23,553 | +16.5% |
| Other amounts receivable | 41 | €114,826 | €92,907 | -€21,919 | -19.1% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €243,955 | €216,889 | -€27,066 | -11.1% |
| Deferred charges and accrued income | 490/1 | €49,623 | €23,493 | -€26,130 | -52.7% |
| Total equity and liabilities | 10/49 | €4,809,464 | €5,106,470 | +€297,006 | +6.2% |
| Equity | 10/15 | -€5,126,815 | -€15,061,403 | -€9.9m | -194% |
| Contributions | 10/11 | €9,040,033 | €9,040,033 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Contributions outside capital | 11 | €8,978,533 | €8,978,533 | = | 0.0% |
| Share premium | 1100/10 | €8,978,533 | €8,978,533 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€14,166,848 | -€24,101,437 | -€9.9m | -70.1% |
| Amounts payable | 17/49 | €9,936,279 | €20,167,873 | +€10.2m | +103% |
| Amounts payable after more than one year | 17 | €7,542,022 | €1,847,346 | -€5.7m | -75.5% |
| Financial debts | 170/4 | €7,542,022 | €1,847,346 | -€5.7m | -75.5% |
| Amounts payable within one year | 42/48 | €2,390,476 | €18,318,006 | +€15.9m | +666% |
| Current portion of amounts payable after more than one year | 42 | €1,292,226 | €15,831,509 | +€14.5m | +1,125% |
| Financial debts | 43 | €16,425 | €1,085,000 | +€1.1m | +6,506% |
| Credit institutions | 430/8 | €16,425 | - | -€16,425 | |
| Other loans | 439 | - | €1,085,000 | +€1.1m | |
| Trade debts | 44 | €909,165 | €1,239,917 | +€330,752 | +36.4% |
| Suppliers | 440/4 | €909,165 | €1,239,917 | +€330,752 | +36.4% |
| Taxes, remuneration and social security | 45 | €172,660 | €161,580 | -€11,079 | -6.4% |
| Taxes | 450/3 | €1,686 | €0 | -€1,686 | -100% |
| Remuneration and social security | 454/9 | €170,974 | €161,580 | -€9,393 | -5.5% |
| Accrued charges and deferred income | 492/3 | €3,781 | €2,521 | -€1,260 | -33.3% |
| Remuneration, social security and pensions | 62 | €2,097,029 | €2,059,799 | -€37,230 | -1.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €902,263 | €1,070,425 | +€168,162 | +18.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €12,600 | - | -€12,600 | |
| Other operating charges | 640/8 | €1,280 | €1,514 | +€233 | +18.2% |
| Gross operating margin | 9900 | -€2,480,259 | -€2,238,685 | +€241,574 | +9.7% |
| Operating profit (loss) | 9901 | -€5,493,431 | -€5,370,422 | +€123,009 | +2.2% |
| Financial income | 75/76B | €15,107 | €5,475 | -€9,632 | -63.8% |
| Recurring financial income | 75 | €15,107 | €5,475 | -€9,632 | -63.8% |
| Financial charges | 65/66B | €324,773 | €4,629,943 | +€4.3m | +1,326% |
| Recurring financial charges | 65 | €324,773 | €4,629,943 | +€4.3m | +1,326% |
| Profit (loss) for the period before taxes | 9903 | -€5,803,098 | -€9,994,890 | -€4.2m | -72.2% |
| Income taxes | 67/77 | -€67,116 | -€60,302 | +€6,814 | +10.2% |
| Profit (loss) for the period | 9904 | -€5,735,982 | -€9,934,588 | -€4.2m | -73.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,735,982 | -€9,934,588 | -€4.2m | -73.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.